ATE203546T1 - Lagerstabile hämoglobinlösungen - Google Patents

Lagerstabile hämoglobinlösungen

Info

Publication number
ATE203546T1
ATE203546T1 AT96920119T AT96920119T ATE203546T1 AT E203546 T1 ATE203546 T1 AT E203546T1 AT 96920119 T AT96920119 T AT 96920119T AT 96920119 T AT96920119 T AT 96920119T AT E203546 T1 ATE203546 T1 AT E203546T1
Authority
AT
Austria
Prior art keywords
stable hemoglobin
hemoglobin solutions
storage
solutions
storage stable
Prior art date
Application number
AT96920119T
Other languages
English (en)
Inventor
Bruce A Kerwin
Douglas L Looker
Original Assignee
Baxter Biotech Tech Sarl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Biotech Tech Sarl filed Critical Baxter Biotech Tech Sarl
Application granted granted Critical
Publication of ATE203546T1 publication Critical patent/ATE203546T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795—Porphyrin- or corrin-ring-containing peptides
    • C07K14/805—Haemoglobins; Myoglobins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
AT96920119T 1995-05-02 1996-05-01 Lagerstabile hämoglobinlösungen ATE203546T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/433,896 US5929031A (en) 1995-05-02 1995-05-02 Storage stable hemoglobin solutions
PCT/US1996/006080 WO1996034889A1 (en) 1995-05-02 1996-05-01 Storage stable hemoglobin solutions

Publications (1)

Publication Number Publication Date
ATE203546T1 true ATE203546T1 (de) 2001-08-15

Family

ID=23721974

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96920119T ATE203546T1 (de) 1995-05-02 1996-05-01 Lagerstabile hämoglobinlösungen

Country Status (7)

Country Link
US (1) US5929031A (de)
EP (1) EP0826004B1 (de)
JP (1) JPH11507016A (de)
AT (1) ATE203546T1 (de)
CA (1) CA2216382A1 (de)
DE (1) DE69614105T2 (de)
WO (1) WO1996034889A1 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6964798B2 (en) 1993-11-16 2005-11-15 Baxter International Inc. Multi-layered polymer based thin film structure for medical grade products
US6242417B1 (en) * 1994-03-08 2001-06-05 Somatogen, Inc. Stabilized compositions containing hemoglobin
US6288027B1 (en) 1995-03-23 2001-09-11 Biopure Corporation Preserving a hemoglobin blood substitute with a transparent overwrap
US6271351B1 (en) 1995-03-23 2001-08-07 Biopure Corporation Method for preserving a hemoglobin blood substitute
US6610832B1 (en) 1995-03-23 2003-08-26 Biopure Corporation Preserving a hemoglobin blood substitute with a transparent overwrap
US6018035A (en) * 1997-07-21 2000-01-25 Baxter International Inc. Reagents for isotropic size enhancement of a peptide, protein, nucleotide or other substrate
US5981710A (en) * 1997-07-21 1999-11-09 Baxter International, Inc. Therapeutic hemoglobin composition having isotropically increased size
US6204254B1 (en) 1997-09-12 2001-03-20 Baxter International, Inc. Biocompatible surfaces and a method for their preparation
KR100674690B1 (ko) * 1999-07-01 2007-01-25 시스멕스 가부시키가이샤 헤모글로빈 안정화수단
JP3466516B2 (ja) * 1999-09-07 2003-11-10 科学技術振興事業団 安定保存可能な酸素輸液剤
US6894150B1 (en) 1999-10-01 2005-05-17 Ross Walden Tye Non-pyrogenic, endotoxin-free, stroma-free tetrameric hemoglobin
US6949384B2 (en) * 2001-12-21 2005-09-27 Spectromedical Inc. Method for monitoring degradation of Hb-based blood substitutes
US7449339B2 (en) * 1999-11-23 2008-11-11 Nir Diagnostics Inc. Spectroscopic method and apparatus for total hemoglobin measurement
FR2809624B1 (fr) * 2000-05-31 2002-08-02 Centre Nat Rech Scient Utilisation comme substitut sanguin d'une hemoglobine extracellulaire de poids moleculaire eleve
US6974447B2 (en) * 2001-04-17 2005-12-13 Baxter International Inc. High gas barrier receptacle and closure assembly
CA2444590C (en) 2001-04-18 2009-12-01 Robert L. Mcginnis Stabilized hemoglobin solutions
US7747315B2 (en) * 2002-01-15 2010-06-29 Board Of Regents, The University Of Texas System Methods and compositions to reduce scattering of light during therapeutic and diagnostic imaging procedures
US7635463B2 (en) * 2002-02-27 2009-12-22 Pharmain Corporation Compositions for delivery of therapeutics and other materials
AU2003219922B2 (en) * 2002-02-27 2009-09-10 Pharmain Corporation Compositions for delivery of therapeutics and other materials, and methods of making and using the same
US20050260259A1 (en) * 2004-04-23 2005-11-24 Bolotin Elijah M Compositions for treatment with glucagon-like peptide, and methods of making and using the same
WO2004007520A2 (en) * 2002-07-12 2004-01-22 Medarex, Inc. Methods and compositions for preventing oxidative degradation of proteins
US7223604B1 (en) * 2002-09-27 2007-05-29 Science & Technology Corporation @ Unm Methods and kits for the detection of erythrocytes
WO2004066953A2 (en) * 2003-01-29 2004-08-12 Northfield Laboratories, Inc. Polymerized hemoglobin solutions having reduced amount of tetramer and method for preparing
EP1763575A4 (de) 2004-04-27 2009-09-23 Baxter Int Rührkesselreaktorsystem
JP2006164312A (ja) * 2004-12-02 2006-06-22 Hitachi Ltd 半導体装置およびそれを用いた磁気記録再生装置
EP1863503B1 (de) 2005-03-07 2019-05-22 Sangart, Inc. Zusammensetzung zur abgabe von kohlenmonoxid (co) und stickoxid (no) an gewebe unter verwendung von heme-proteinen als träger
EP1978802A2 (de) * 2006-01-24 2008-10-15 Northfield Laboratories, Inc. Polymerisiertes hämoglobinmedium und verwendung davon bei der isolierung und transplantation von inselzellen
US20090004159A1 (en) * 2006-01-24 2009-01-01 The Board Of Trustees Of The University Of Illinoi Polymerized Hemoglobin Media and Its Use in Isolation and Transplantation of Islet Cells
US7494974B2 (en) * 2006-10-24 2009-02-24 Ikor, Inc. Carboxymethylated cross-linked tetrameric hemoglobin
US7504377B2 (en) * 2006-10-23 2009-03-17 Ikor, Inc. Nitric oxide-blocked cross-linked tetrameric hemoglobin
JP2008195656A (ja) * 2007-02-14 2008-08-28 Nipro Corp 人工酸素運搬体製剤
US8609815B2 (en) 2010-09-02 2013-12-17 Sangart, Inc. Methods for preparing stable deoxygenated PEG-hemoglobin conjugate solutions comprising an antioxidant
US9199026B2 (en) * 2011-01-07 2015-12-01 Somerset Group Enterprises, Inc. Modular extracorporeal systems and methods for treating blood-borne diseases
US9375525B2 (en) 2012-01-09 2016-06-28 Somerset Group Enterprises, Inc. Modular extracorporeal systems and methods for treating blood-borne diseases
US9763889B2 (en) * 2015-06-29 2017-09-19 Billion King International Ltd. Oral delivery system for hemoglobin based oxygen carriers
US10052290B2 (en) * 2016-02-04 2018-08-21 Billion King International Ltd. Enteric-coated hemoglobin multiparticulate for oral delivery of hemoglobin based oxygen carriers
US20230324412A1 (en) * 2020-04-09 2023-10-12 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and compositions to determine the quality of red blood cell units

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3144705C2 (de) * 1981-11-11 1983-12-08 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Verfahren zur Herstellung eines lagerstabilen, vernetzten Hämoglobinpräparates mit hoher Sauerstoff-Transportkapazität, sowie das nach diesem Verfahren hergestellte Hämoglobinpräparat
US4727027A (en) * 1983-05-02 1988-02-23 Diamond Scientific Co. Photochemical decontamination treatment of whole blood or blood components
US4861867A (en) * 1988-02-03 1989-08-29 Baxter International, Inc. Purified hemoglobin solutions and method for making same
US5234903A (en) * 1989-11-22 1993-08-10 Enzon, Inc. Chemically modified hemoglobin as an effective, stable non-immunogenic red blood cell substitute
US5352773A (en) * 1990-08-06 1994-10-04 Baxter International Inc. Stable hemoglobin based composition and method to store same
DE69115011T2 (de) * 1990-08-06 1996-04-18 Baxter International Inc., Deerfield, Ill. Stabiles mittel auf hämoglobinbasis und verfahren zu dessen einlagerung.
WO1992008478A1 (en) * 1990-11-20 1992-05-29 Enzon, Inc. Method of enhancing long-term storage stability of hemoglobin products
SE9301581D0 (sv) * 1993-05-07 1993-05-07 Kabi Pharmacia Ab Protein formulation

Also Published As

Publication number Publication date
US5929031A (en) 1999-07-27
DE69614105T2 (de) 2002-03-21
WO1996034889A1 (en) 1996-11-07
EP0826004A1 (de) 1998-03-04
CA2216382A1 (en) 1996-11-07
AU5852096A (en) 1996-11-21
EP0826004B1 (de) 2001-07-25
DE69614105D1 (de) 2001-08-30
AU708264B2 (en) 1999-07-29
JPH11507016A (ja) 1999-06-22

Similar Documents

Publication Publication Date Title
DE69614105D1 (de) Lagerstabile hämoglobinlösungen
DE69401204D1 (de) Gonadotropin enthaltende gefriergetrocknete troepfen
YU23599A (sh) Stabilizovani antihistaminski sirup
BG102894A (en) Aryl-heterocyclic salts-including complexes
TR199901473T2 (xx) Ha�ere �ld�r�c� 1-arilpirazoller
ATE291917T1 (de) Topisch anzuwendende ketoconazol enthaltende emulsionen
MX9605665A (es) Bis (resorcinil) triazinas.
ES2096497T3 (es) Procedimiento para la obtencion de aminoalcoholes opticamente activos.
IL147676A0 (en) Improvement of spermatozoa fertilization activity
EA199700032A1 (ru) Дезинфицирующий состав "велтолен"
MY103241A (en) Imidazole and 1,2,4 triazole derivatives
NZ319138A (en) Composition containing cytochrome complex III and fenazaquin for combatting parasitic fungi
ATE232686T1 (de) Sporizide zusammensetzung
TR200101315T2 (tr) Ağartıcı terkipleri.
CA2067371A1 (en) Stable hemoglobin based composition and method to store same
ES2154659T3 (es) Soluciones acuosas de isotiazolin-3-onas estables al almacenamiento.
TR199701617T1 (xx) �iftliklerde �retilen bal�klarda g�r�len parazitlerle m�cadelede kullan�lacak bir ajan.
ES8504434A1 (es) Procedimiento para preparar una composicion fungicida a base de una sal de acido alquil-fosforoso
AU7028798A (en) Use of 2-methylthiazolidine-2,4-dicarboxylic acid as mucolytic agent
FR2720938B1 (fr) Composition dermato-cosmétologique et son utilisation.
FR2740337B1 (fr) Compositions pharmaceutiques stabilisees contenant un derive ayant une activite adrenergique
ATE226614T1 (de) Wässrige reaktivfarbstoff-preparate, deren herstellung und deren verwendung
DK0713485T3 (da) Thiocarbamoylforbindelser som mikrobicider
TR23745A (tr) 1-dimetilkarbomoil-3-suebstituee 1h-1.2.4-triazoller
IT8720208A0 (it) Macchina per l'impiego forestale destinata in particolare per la lavorazione di alberi.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties